120 related articles for article (PubMed ID: 25182706)
21. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
Fan J; Yu H; Lv Y; Yin L
Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
[TBL] [Abstract][Full Text] [Related]
22. Quantitative reverse transcription-PCR assay for detection of mRNA encoding full-length human tissue kallikrein 7: prognostic relevance of KLK7 mRNA expression in breast cancer.
Holzscheiter L; Biermann JC; Kotzsch M; Prezas P; Farthmann J; Baretton G; Luther T; Tjan-Heijnen VC; Talieri M; Schmitt M; Sweep FC; Span PN; Magdolen V
Clin Chem; 2006 Jun; 52(6):1070-9. PubMed ID: 16627559
[TBL] [Abstract][Full Text] [Related]
23. [Clinical significance of serum squamous cell carcinoma antigen in patients with early cervical squamous cell carcinoma].
Li D; Xu XX; Yan DD; Yuan SH; Lou HM
Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):357-362. PubMed ID: 31137169
[No Abstract] [Full Text] [Related]
24. Influence of serum VEGF levels on therapeutic outcome and diagnosis/prognostic value in patients with cervical cancer.
Du K; Gong HY; Gong ZM
Asian Pac J Cancer Prev; 2014; 15(20):8793-6. PubMed ID: 25374209
[TBL] [Abstract][Full Text] [Related]
25. Expression analysis of the human kallikrein 7 (KLK7) in breast tumors: a new potential biomarker for prognosis of breast carcinoma.
Talieri M; Diamandis EP; Gourgiotis D; Mathioudaki K; Scorilas A
Thromb Haemost; 2004 Jan; 91(1):180-6. PubMed ID: 14691584
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of kallikrein-related peptidase 7 (KLK7) mRNA expression in advanced high-grade serous ovarian cancer.
Gong W; Liu Y; Diamandis EP; Kiechle M; Bronger H; Dorn J; Dreyer T; Magdolen V
J Ovarian Res; 2020 Oct; 13(1):125. PubMed ID: 33087135
[TBL] [Abstract][Full Text] [Related]
27. Modified Glasgow prognostic score is an independent prognostic factor in patients with cervical cancer undergoing chemoradiotherapy.
Xiao Y; Ren YK; Cheng HJ; Wang L; Luo SX
Int J Clin Exp Pathol; 2015; 8(5):5273-81. PubMed ID: 26191228
[TBL] [Abstract][Full Text] [Related]
28. Serum Cripto-1 is a novel biomarker for non-small cell lung cancer diagnosis and prognosis.
Xu CH; Wang Y; Qian LH; Yu LK; Zhang XW; Wang QB
Clin Respir J; 2017 Nov; 11(6):765-771. PubMed ID: 26605871
[TBL] [Abstract][Full Text] [Related]
29. Predictive role of serum cholesterol and triglycerides in cervical cancer survival.
Lin F; Zheng R; Yu C; Su Y; Yan X; Qu F
Int J Gynecol Cancer; 2021 Feb; 31(2):171-176. PubMed ID: 33051246
[TBL] [Abstract][Full Text] [Related]
30. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
Yang L; Xu Q; Xie H; Gu G; Jiang J
Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
[TBL] [Abstract][Full Text] [Related]
31. Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer.
Wang SY; Li Y; Jiang YS; Li RZ
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4092-4097. PubMed ID: 29028091
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic performance of MR imaging in evaluating prognostic factors in patients with cervical cancer: a meta-analysis.
Xiao M; Yan B; Li Y; Lu J; Qiang J
Eur Radiol; 2020 Mar; 30(3):1405-1418. PubMed ID: 31776741
[TBL] [Abstract][Full Text] [Related]
33. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.
Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M
BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349
[TBL] [Abstract][Full Text] [Related]
34. Potential prognostic factors in progression-free survival for patients with cervical cancer.
Chen HH; Meng WY; Li RZ; Wang QY; Wang YW; Pan HD; Yan PY; Wu QB; Liu L; Yao XJ; Kang M; Leung EL
BMC Cancer; 2021 May; 21(1):531. PubMed ID: 33971846
[TBL] [Abstract][Full Text] [Related]
35. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
Wu F; Chen L; Wu W; Jiang B; Su X
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
[TBL] [Abstract][Full Text] [Related]
36. Clinical value of protein expression of kallikrein-related peptidase 7 (KLK7) in ovarian cancer.
Dorn J; Gkazepis A; Kotzsch M; Kremer M; Propping C; Mayer K; Mengele K; Diamandis EP; Kiechle M; Magdolen V; Schmitt M
Biol Chem; 2014 Jan; 395(1):95-107. PubMed ID: 23999494
[TBL] [Abstract][Full Text] [Related]
37. Detecting of p16 Autoantibody as a Potential Early Diagnostic Serum Biomarker in Patients with Cervical Cancer.
Huangfu M; Liu L; Xu S; Li S; Jiang K; Sun B; Lee KH; Sun S
Clin Lab; 2016; 62(6):1117-20. PubMed ID: 27468574
[TBL] [Abstract][Full Text] [Related]
38. Unfavorable prognostic value of human kallikrein 7 quantified by ELISA in ovarian cancer cytosols.
Shan SJ; Scorilas A; Katsaros D; Rigault de la Longrais I; Massobrio M; Diamandis EP
Clin Chem; 2006 Oct; 52(10):1879-86. PubMed ID: 16916986
[TBL] [Abstract][Full Text] [Related]
39. Elevated serum interleukin-37 level is a predictive biomarker of poor prognosis in epithelial ovarian cancer patients.
Huo J; Hu J; Liu G; Cui Y; Ju Y
Arch Gynecol Obstet; 2017 Feb; 295(2):459-465. PubMed ID: 27975129
[TBL] [Abstract][Full Text] [Related]
40. DKK-1 in serum as a clinical and prognostic factor in patients with cervical cancer.
Jiang T; Huang L; Zhang S
Int J Biol Markers; 2013 Jun; 28(2):221-5. PubMed ID: 23595579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
